New Targeted Lung Cancer Drug, Retevmo, So Effective It Gave Musician His Life Back

Updated November 5th, 2020

New Targeted Lung Cancer Drug, Retevmo, So Effective It Gave Musician His Life Back

RET+ lung cancers are aggressive and have a poor prognosis, but new targeted drug selpercatinib (Retevmo) benefits more than 90% of patients who have this type of cancer.

NOW
PLAYING
5 COVID-19 Vaccine Questions Answered by Expert Physician
NOW
PLAYING
The First Targeted Therapy For Lung Cancer Patients With The KRAS Gene Mutation--Extraordinary Results With Sotorasib
NOW
PLAYING
New Treatment Shows Huge Promise For Decreasing COVID Symptom-- Are Monoclonal Antibodies An Option for Cancer Patients?
NOW
PLAYING
Former & Current Heavy Smokers Should Get Lung Cancer Screenings Using CT Scan, Says Leading Expert
NOW
PLAYING
There Is New Hope for Those Fighting the Same Cancer That Took John McCain & Ted Kennedy; Using Polio & Immunotherapy to Fight Brain Tumors
NOW
PLAYING
Some Good Advice from Her Nurse Helped Ovarian Cancer Survivor Marecya Burton Minimize Scars During Chemo
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.